Status:
COMPLETED
Does Botulinum Toxin Type-A Injection an Effective Way of Relieving Pain in Myofascial Pain Syndrome Patients or Not
Lead Sponsor:
Bursa City Hospital
Conditions:
Myofacial Pain Syndromes
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
In this research prilocaine and botulinum toxin (BoNT-A) interventions prospectively compared to find out the effect of BoNT-A injection on myofascial pain syndrome (MPS). The main question it aims t...
Detailed Description
Visual Analog Scale (VAS), 4-Point Verbal Rating Scale (VRS), Pain Pressure Threshold (PPT), Short Form-36 (SF-36) and Beck Depression Inventory (BDI) tools were used to evaluate findings of the resea...
Eligibility Criteria
Inclusion
- Age ≥ 20 years
- Presence of myofascial pain syndrome (MPS) symptoms for more than 3 months
- Ability and willingness to provide written informed consent
Exclusion
- Any injection to trigger points within the last 2 months
- Diagnosis of fibromyalgia syndrome
- Presence of significant respiratory or cardiovascular disease
- Presence of psychiatric disorders that may interfere with study participation
- History of shoulder or cervical spine intervention within the last year
- Presence of cervical myelopathy or cervical radiculopathy
- Inability to cooperate with study procedures or assessments
Key Trial Info
Start Date :
August 26 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 26 2010
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT06899438
Start Date
August 26 2009
End Date
January 26 2010
Last Update
January 9 2026
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.